Lauffer, Marten C. (2021). Organ-on-a-chip technologies to study neuromuscular disorders: possibilities, limitations, and future hopes. Med. Genet., 33 (3). S. 261 - 268. BERLIN: WALTER DE GRUYTER GMBH. ISSN 1863-5490

Full text not available from this repository.

Abstract

Neuromuscular disorders are a heterogeneous group of diseases ranging from mild to devastating phenotypes depending on the disorder's origin. Pathophysiologies for many of these disorders are not fully understood and efficient therapies are urgently needed. Recent advances in the field of induced pluripotent stem cells and organ-on-a-chip technologies have brought enormous improvement in modeling neuromuscular diseases. Even complex units, like the neuromuscular junction, can now be built, enabling researchers to study each component of the motor unit by itself or interacting with others, allowing the identification of disease mechanisms. This article aims to introduce these new modeling systems to study neuromuscular disorders and the possibilities of organ on-a-chip platforms to shed light on disease pathologies and their use for therapy development.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Lauffer, Marten C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-566383
DOI: 10.1515/medgen-2021-2085
Journal or Publication Title: Med. Genet.
Volume: 33
Number: 3
Page Range: S. 261 - 268
Date: 2021
Publisher: WALTER DE GRUYTER GMBH
Place of Publication: BERLIN
ISSN: 1863-5490
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
GENERATIONMultiple languages
Genetics & HeredityMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/56638

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item